menu
    • menu

    Company profile for MiNK Therapeutics

    NEW Drugs in Dev: 3
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MiNK Therapeutics is a clinical-stage precision oncology company developing allogeneic, invariant natural killer T cell therapies for cancer and other immune-mediated diseases. The lead product is an off-the-shelf, cell therapy based on a targeted platform of invariant natural killer T (iNKT) cells. iNKTs have a dual-mechanism of action with an internal targeting and homing device (iTCR) that modulates both arms of immunity, i...
    MiNK Therapeutics is a clinical-stage precision oncology company developing allogeneic, invariant natural killer T cell therapies for cancer and other immune-mediated diseases. The lead product is an off-the-shelf, cell therapy based on a targeted platform of invariant natural killer T (iNKT) cells. iNKTs have a dual-mechanism of action with an internal targeting and homing device (iTCR) that modulates both arms of immunity, innate and adaptive. iNKTs combine the killing features of natural killer (NK) cells with the durable memory response of T cells.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MiNK TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    149 Fifth Avenue Suite 500 New York, NY 10010
    Telephone
    Telephone
    212.994.8250
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://minktherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/minktherapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/MiNK_iNKT

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MiNK Launches Phase 1 AGENT-797 Trial for GVHD
    MiNK Launches Phase 1 AGENT-797 Trial for GVHD

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215679/0/en/MiNK-Therapeutics-and-University-of-Wisconsin-Madison-Announce-Phase-1-Clinical-Trial-of-Allo-iNKT-Cell-Therapy-AgenT-797-to-Evaluate-Prevention-of-Graft-Versus-Host-Disease.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    Mink Therapeutics Reveals Mink-215's Strong Anti-Tumor Activity
    Mink Therapeutics Reveals Mink-215's Strong Anti-Tumor Activity

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3192212/0/en/MiNK-Therapeutics-Announces-New-Data-Showing-MiNK-215-Drives-Potent-Anti-Tumor-Activity-in-Treatment-resistant-Solid-Tumors.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share
    MiNK Therapeutics Reports Q3 Results & Accelerates iNKT Platform
    MiNK Therapeutics Reports Q3 Results & Accelerates iNKT Platform

    14 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/14/3188228/0/en/MiNK-Therapeutics-Reports-Q3-2025-Results-and-Accelerates-iNKT-Platform-Toward-Pivotal-Development-Across-Oncology-Pulmonary-Disease-and-Transplantation.html

    GLOBENEWSWIRE
    14 Nov 2025
    Share Share
    Mink Therapeutics Reveals Allo-Inkt Cell Therapy Agent-797
    Mink Therapeutics Reveals Allo-Inkt Cell Therapy Agent-797

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183675/0/en/MiNK-Therapeutics-Reports-Durable-Responses-and-Immune-Reactivation-with-Allo-iNKT-Cell-Therapy-agenT-797-in-PD-1-Refractory-Solid-Tumors-at-SITC-2025.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Mink Therapeutics To Showcase Q3 Financials & Progress Update
    Mink Therapeutics To Showcase Q3 Financials & Progress Update

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181582/0/en/MiNK-Therapeutics-to-Report-Third-Quarter-2025-Financial-Results-and-Highlight-Clinical-and-Corporate-Milestones-Advancing-iNKT-Platform-Toward-Pivotal-Development.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    Mink Therapeutics to Unveil Agent-797 Data at SITC Conference
    Mink Therapeutics to Unveil Agent-797 Data at SITC Conference

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/30/3177489/0/en/MiNK-Therapeutics-to-Present-Late-Breaking-Data-on-AgenT-797-in-Solid-Tumors-at-the-40th-Annual-Society-for-Immunotherapy-of-Cancer-SITC-Meeting.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search